Copyright©2018 CSIR-Institute of Genomics and Integrative Biology | VS Lab |
hsa_circ_0064428 | |||
Gene | SLC6A6 | Organism | Human |
Genome Locus | chr3:14487224-14520076:+ | Build | hg19 |
Disease | Hepatocellular Carcinoma | ICD-10 | Liver cell carcinoma (C22.0) |
DBLink | Link to database | PMID | 30120213 |
Experimental Method | |||
Sample Type | plasma and tumour tissue samples | Comparison | 120 participants who were diagnosed with HCC were included in this study. These patients contained an equal number of men and women at different tumour stages |
Method for Estimation | Quantitative PCR and Microarrays | PCR Details | |
Primers (Predicted) | Suggested Primers | Statistics | Fold Change : Downregulated pvalue : p<0.05 |
Citation | |||
Weng, Q, Chen, M, Li, M, Zheng, YF, Shao, G, Fan, W, Xu, XM, Ji, J (2019). Global microarray profiling identified hsa_circ_0064428 as a potential immune-associated prognosis biomarker for hepatocellular carcinoma. J. Med. Genet., 56, 1:32-38. |